ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Personal Finance
  • Adani Saga
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Real Estate
    • Home Buyers
    • Builders
  • Axis MF
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » Companies News

Biocon Q3 net up 65% to Rs 171 crore

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Biocon Q3 net up 65% to Rs 171 crore
The commercialisation of the company's Malaysian facility was a key milestone this quarter. Photo: IANS

Biotechnology major Biocon today reported a 64.55 per cent rise in its consolidated net profit to Rs 171.3 crore for the third quarter ended December 31, led by robust growth of biologics business.

The company had posted a net profit after taxes, minority interest and share of profit from associates of Rs 104.1 crore for the corresponding period of the previous fiscal, Biocon said in a filing to BSE.

Consolidated total income from operations also rose to Rs 1,044.4 crore for the quarter under consideration as against Rs 807.1 crore for the same period year ago.

Biocon Chairperson and MD Kiran Mazumdar-Shaw said, "Our strong performance in Q3 FY17 was led by robust growth of our biologics business with both insulins and biosimilar MAbs gaining traction in Japan and key emerging markets".

The commercialisation of the company's Malaysian facility was a key milestone this quarter, she added.

"Other major milestones this quarter were the acceptance of our first biologics license application (BLA) for the proposed biosimilar Trastuzumab by USFDA and marketing authorisation application (MAA) for insulin Glargine by EMA," Mazumdar-Shaw said. 

The company's small molecules and research services business also reported strong growth this quarter, she added. 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
BioconBiocon Q3 resultBiocon Q3 net profitBiocon total incomeKiran Mazumdar-Shawbiotechnology products
Written By: PTI
Updated: Wed, Jan 25, 2017
08:23 am
New Delhi, PTI
RELATED NEWS
Women's Day Special: Billionaire Indian women making waves in corporate world Women's Day Special: Billionaire Indian women making waves in corporate world
Can you expect healthy growth in pharma stocks now? Here's what top brokerages recommend Can you expect healthy growth in pharma stocks now? Here's what top brokerages recommend
Traders Diary on 20 stocks: Buy, Sell or Hold strategy on L&T Tech, Sun Pharma, Finolex Industries, Vedanta, Biocon and others Traders Diary on 20 stocks: Buy, Sell or Hold strategy on L&T Tech, Sun Pharma, Finolex Industries, Vedanta, Biocon and others
Biocon Q4 results: Consolidated revenue growth recorded at Rs 2,476 Cr, up by 21% Biocon Q4 results: Consolidated revenue growth recorded at Rs 2,476 Cr, up by 21%
Biocon share price dives 11% after its subsidiary announced deal to acquire Viatris Biocon share price dives 11% after its subsidiary announced deal to acquire Viatris

LATEST NEWS

Pune-based LoanTap buys healthcare-focused fintech startup Unofin

UPI transactions above Rs 2,000 to be chargeable from April 1? NPCI clarifies

Apple rolls out iOS 16.5 beta 1 to developers

Samsung introduces premium range of Robotic, Bespoke vacuum cleaners in India: Check price and other details

Over 9.79 lakh vacant posts in govt, maximum of 2.93 lakh in railways: Centre

Upgrad raises Rs 300 cr in rights issue led by co-founder Ronnie Screwvala

Not SBI, HDFC Bank, these smaller lenders offer higher FD interest rates — compare returns here

Nifty reclaims 17,000, Sensex follows suit led by HDFC twins, ICICI Bank, Infosys, ITC

Honda announces two new electric two-wheelers with swappable batteries, aims to roll out 1 million EVs per year by 2030

IPL 2023: From MS Dhoni to Piyush Chawla: These five players are likely to bid farewell to their IPL career

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. Indiadotcom Digital Private Limited. All Rights Reserved.
LIVE TV